Bisphosphonate Therapy Ameliorates Hearing Loss in Mice Lacking Osteoprotegerin
Authors:
- 1 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 24 (1) , 43-49
Abstract
Three auditory ossicles including the malleus, incus, and stapes conduct sound in the middle ear from the tympanic membrane to the inner ear. Auditory ossicles are massively resorbed by osteoclasts in Opg−/− mice, which lack osteoprotegerin (OPG), a soluble decoy receptor for the osteoclastogenic cytokine RANKL. Opg−/− mice exhibit progressive hearing loss and are a model for juvenile Paget's disease. However, effects of antiresorptive treatment on auditory ossicles and on hearing function in Opg−/− mice are unknown. We intraperitoneally injected Opg−/− mice with bisphosphonate risedronate 5 d/wk for 9 wk. Morphology of auditory ossicles was examined microscopically, radiographically, and histologically. Hearing function was monitored by measuring the auditory brain stem response (ABR). Control Opg−/− mice exhibited thinning of all three ossicles and tibia. In contrast, risedronate treatment significantly inhibited bone loss in auditory ossicles as well as in long bones of Opg−/− mice. Bony fusion of the junction between the stapes and the otic capsule was reduced after treatment. Moreover, ABR measurement showed that hearing in Opg−/− mice was significantly improved by risedronate treatment. These data suggest that hearing loss in pathologies characterized by excessive resorption of the auditory ossicles may be prevented by bisphosphonates.Keywords
This publication has 33 references indexed in Scilit:
- Bone quality: the material and structural basis of bone strengthJournal of Bone and Mineral Metabolism, 2008
- Repair of a Malleus‐Handle Fracture Using Calcium Phosphate Bone CementThe Laryngoscope, 2007
- Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerinBone, 2006
- Osteoclast-derived activity in the coupling of bone formation to resorptionTrends in Molecular Medicine, 2005
- Osteoprotegerin in the Inner Ear May Inhibit Bone Remodeling in the Otic CapsuleThe Laryngoscope, 2005
- Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapyBone, 2004
- The Mechanism of Hearing Loss in Paget's Disease of BoneThe Laryngoscope, 2004
- Malleal processus brevis is dispensable for normal hearing in miceDevelopmental Dynamics, 2003
- Inhibition of Cholesteatomatous Bone Resorption with Pamidronate DisodiumActa Oto-Laryngologica, 2001
- Fosl1 is a transcriptional target of c-Fos during osteoclast differentiationNature Genetics, 2000